APA (7th ed.) Citation

Perez, E. A., Barrios, C., Eiermann, W., Toi, M., Im, Y., Conte, P., . . . Burris, H. A. 3. (2019). Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE. Cancer (0008543X), 125(22), 3974. https://doi.org/10.1002/cncr.32392

Chicago Style (17th ed.) Citation

Perez, Edith A., et al. "Trastuzumab Emtansine with or Without Pertuzumab Versus Trastuzumab with Taxane for Human Epidermal Growth Factor Receptor 2-positive Advanced Breast Cancer: Final Results from MARIANNE." Cancer (0008543X) 125, no. 22 (2019): 3974. https://doi.org/10.1002/cncr.32392.

MLA (9th ed.) Citation

Perez, Edith A., et al. "Trastuzumab Emtansine with or Without Pertuzumab Versus Trastuzumab with Taxane for Human Epidermal Growth Factor Receptor 2-positive Advanced Breast Cancer: Final Results from MARIANNE." Cancer (0008543X), vol. 125, no. 22, 2019, p. 3974, https://doi.org/10.1002/cncr.32392.